Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.01
50% from low
Borrow rate
20.92%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58.3M | $100.4M | $86.7M | $89.5M | $96.0M | $73.2M | $62.6M | $67.0M |
| Cost of revenue | $34.8M | $72.3M | $41.5M | $44.3M | $38.4M | $29.2M | $27.8M | $28.8M |
| Gross profit | $23.5M | $28.0M | $45.2M | $45.2M | $57.5M | $43.9M | $34.8M | $38.2M |
| Gross margin | 40.3% | 27.9% | 52.1% | 50.5% | 60.0% | 60.1% | 55.6% | 57.0% |
| R&D | $23.8M | $61.6M | $33.9M | $20.9M | $19.1M | $17.3M | $19.7M | $23.0M |
| Operating income | −$70.9M | −$161.5M | −$67.9M | −$50.7M | −$30.8M | −$26.3M | −$40.9M | −$51.3M |
| EBITDA | −$28.9M | −$127.0M | −$98.2M | −$154.6M | −$27.2M | −$53.0M | −$29.1M | −$38.5M |
| Net income | −$72.0M | −$184.1M | −$175.2M | −$192.2M | −$62.8M | −$56.3M | −$58.3M | −$67.8M |
| Net margin | -123.5% | -183.4% | -202.1% | -214.8% | -65.4% | -77.0% | -93.0% | -101.2% |
| EPS (diluted) | -8.95 | -24.74 | -22.51 | -26.40 | -8.53 | -7.61 | -7.66 | -8.80 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $170M | $1.35 | $1.35–$1.35 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds NHIQ.
No tracked institution reports a position in NHIQ as of their last filing.
No one on the platform has traded NHIQ yet.
| +0.00% |
| $115917 |
| — |
| HURATuHURA Biosciences, Inc. | $2.29 | -0.22% | $146M | — |
| LNDZFEvome Medical Technologies Inc. | $0.00 | +0.00% | $5981 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$IBRX $NHIQ it’s ok bro, no need for confirmations, we already knew you were a looser
View on StockTwits ↗@tothebulltothewall I told you both. All you have to do is look at $NHIQ TO KNOW WHERE THIS IS GOING. That stock used to cost 5$ a share too 😂😂😂
View on StockTwits ↗$IBRX I remember when I bought $NHIQ for 5$ and then 2 years later it was .012
View on StockTwits ↗@AL912 heard of $NHIQ ?? Go do some research on Dr. Pats last stock
View on StockTwits ↗$IBRX do some research on $NHIQ before buying! Would any bulls like to debate me on this topic? lol
View on StockTwits ↗@tothebulltothewall $NHIQ is all you need to look into
View on StockTwits ↗$IBRX $NHIQ they’ve been pumping for years
View on StockTwits ↗$IBRX you guys are morons. all dr pat did was pump this like his old company $NHIQ look into it
View on StockTwits ↗$IBRX once people realize this is $NHIQ part 2 it will be legendary. down 60% in a single day legendary
View on StockTwits ↗$IBRX so can anyone explain to me what happened to his last company $NHIQ ??? or did you get your DD from some idiot on here saying gama squeeze incoming just hold
View on StockTwits ↗$IBRX i changed my position. i am now short. i didnt realize Dr. Pat had another scam pump and dump in the past. Nant health $NHIQ LOL
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.